Every minute of high intensity physical activity counts in the war against weight gain.

Regular physical activity is a cornerstone of diabetes management and can drop blood sugars by 12% if done after dinner.

Early intervention in treating diabetes has shown long term benefits, follow-up data for both old and new studies show.

International study explores the role of physical exertion, anger, and emotional upset in triggering acute myocardial infarction.

Most insurance plans will be dropping Lantus from formularies.

These factors are tied to increased nephropathy risk in type 2 diabetes patients.

There are a number of studies saying that calcium supplements may not be heart safe.

The overall profile of sodium-glucose cotransporter 2 inhibitors suggests they are a reliable, second-line therapy choice for adults with type 2 diabetes. However, the class is associated with possible side effects that should be carefully considered, according to a Dr. George L. Bakris, MD, director of the ASH Comprehensive Hypertension Center at the University of Chicago Medicine at a recent presentation at the Cardiometabolic Health Congress. Dr. Bakris stated that they definitely are preferred second-line agents, absolutely over sulfonylureas, and probably over thiazolidinediones and some other agents as well.

In part 2 of this exclusive ADA interview, Anthony Cincotta discusses the Cycloset Safety Trial study design and findings regarding the cardiovascular safety of Cycloset.

In part 1 of this exclusive ADA interview, Anthony Cincotta discusses the mechanistic science behind the development of Cycloset, and why preclinical and clinical findings suggest the therapy may reset clock mechanisms governing postprandial glucose metabolism.